Last reviewed · How we verify

NCT07278973: HD-OLDER

Hemodiafiltration Versus Hemodialysis in Older People

Recruiting now NA Last updated 23 February 2026
What this trial tests

NA trial testing High-flux hemodialysis in Hemodialysis in 62 participants. Currently enrolling.

Timeline
19 February 2026
Primary endpoint
19 December 2026
19 December 2026

Quick facts

Lead sponsorAUB Santé
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeother
Enrollment62
Start date19 February 2026
Primary completion19 December 2026
Estimated completion19 December 2026
Sites4 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

AUB Santé

Who can join

85 and older, any sex, with Hemodialysis or Hemodiafiltration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will compare the impact of two hemodialysis techniques on fatigue and post-dialysis recovery time in patients aged 85 years and older. These two techniques are high-flux hemodialysis (HD) and hemodiafiltration (HDF). Patients will receive the treatment over two periods: if period 1 is HD then period 2 will be HDF. Every patient will be his/her own control, this is why it is called cross-over. Each period will last three months. Between the two periods, patients will receive a traditional low-flux hemodialysis. These two techniques are widely used worldwide and their side-effects are well-known and do not put the patients at risk. HDF has been shown to improve survival in patients with a mean age of 58 years. But a previous study from the investigators' group showed that HDF causes a prolonged recovery time in older patients. This randomized trial aims to elucidate this question.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of High-flux hemodialysis

Trials testing the same drug.

Other recruiting trials for Hemodialysis

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07278973.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing